The Objectives of this conference are:
1. Discuss new developments in Generics and Biosimilars regionally over the last 12 months.
2. Bring together Key Opinion Leaders in the Gulf and Middle East from pharmaceutical companies, CEO’s of hospitals & health management organizations, as well as researchers to speak about best practices in business and the market place. This includes specialty Business to Business strategic meetings and networking facilitated by special smart phone and tablet applications.
3. Host a variety of speakers to have a meaningful discussion innovative pharmaceutical technology and intellectual property in generics and biosimilars.
This is a great chance to meet and hear from key regional players:
Dr.Tawfik Khoja, Director General of the GCC Health Ministers Council
Hayel Obeidat, Jordan Food and Drug Administration
This is our 5th conference about Generics, and we expect 150-200 delegates from various fields: physicians, pharmaceutical companies, pharmacists, insurance companies, and regulatory agencies from the UAE and Gulf region. This year we address developments in Generics and Biosimilar industries, as well as legal aspects and challenges of production in each various countries in the region. The cost of attendance is now only AED 1200 early bird special, and sponsorship packages begin at AED 17,000. Register today. Group discounts are available for 3 or more people.
Please see our website, or contact Program Director Erica Aisha Charves for more information.
Click Here to Register: http://www.mco.ae/GenericMedicine/register.php
Click Here to see the website: http://www.mco.ae/GenericMedicine/
Click Here for Hotel Booking: http://www.rotana.com/rayhaanhotelandresorts/unitedarabemirates/dubai/alghurairrayhaanbyrotana
Program Director - MCO
T - +971 2 658 8717 | +971 2 627 5509
M - +971 55 404 8142
E - email@example.com W -http://www.mco.ae